What's New

The Challenges at the Intersection of VTE and Obesity: Defining the Issues
Rachel P. Rosovsky, MD, MPH; Stephan Moll, MD; and Bishoy Ragheb, PharmD, BCACP, CDE, CACP, CTTS
This activity, the first in a two-part series, focuses on the effects of obesity on VTE and anticoagulation therapy. Follow along with the faculty as they clarify the relationship between obesity and VTE and outline strategies for tailoring anticoagulation therapy based on body mass index (BMI) and other relevant factors. A case study is included to help demonstrate the challenges of – and solutions to – anticoagulation therapy in this patient population
.
Anticoagulation in Obese Patients: Applied Clinical Practices in the Non-specialist Setting
Rachel P. Rosovsky, MD, MPH; Stephan Moll, MD; and Bishoy Ragheb, PharmD, BCACP, CDE, CACP, CTTS
This activity, the second in a two-part series, explores anticoagulation treatment strategies in special patient groups, including patients with heavy menses, renal issues, or a history of bariatric surgery. This activity is designed to equip its participants with strategies for ensuring optimal anticoagulation in a variety of situations in patients both with and without obesity.
.
Monograph-The Role of Care Transitions in Critical Access Hospitals
This monograph details the beneficial effects of a targeted Care Transition Intervention (CTI) on VTE outcomes in Black rural populations. This program, which was piloted in a Critical Access Hospital catchment region in Mississippi, demonstrates how CTIs might reduce VTE-associated hospital readmissions in underserved populations. Explore this important study and its implications for VTE care across the country.
VTE Risk Assessment Tool
How do you estimate the pretest probability for acute DVT and PE?

© 2024 MediCom Worldwide, Inc. All rights reserved